Cannabis Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Brand (Sativex, Epidiolex, Others), by Region, Country, Segment, and Companies, 2024-2030

Cannabis Pharmaceuticals Market Size, Trends, Analysis, and Outlook By Brand (Sativex, Epidiolex, Others), by Region, Country, Segment, and Companies, 2024-2030

The global Cannabis Pharmaceuticals market size is poised to register 35.19% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Cannabis Pharmaceuticals market across By Brand (Sativex, Epidiolex, Others).

The Cannabis Pharmaceuticals Market is experiencing notable growth and therapeutic innovation in 2024 and beyond, driven by advancements in cannabinoid pharmacology, drug delivery technology, and pharmaceutical formulation science aimed at developing pharmaceutical-grade cannabis medications, cannabinoid-based drugs, and cannabinoid-derived pharmaceuticals for treating various medical conditions, neurological disorders, and psychiatric disorders in patients with unmet medical needs, treatment-resistant symptoms, or refractory disease states that require novel pharmacotherapeutic approaches, precision medicine interventions, and evidence-based treatment regimens for achieving therapeutic efficacy, symptom relief, and disease management goals in clinical practice. Cannabis pharmaceuticals encompass a diverse range of pharmaceutical formulations, dosage forms, and drug delivery systems, including oral capsules, sublingual tinctures, transdermal patches, metered-dose inhalers, and topical creams, that deliver precise doses of cannabinoids, cannabinoid analogs, or cannabinoid derivatives to target tissues, organ systems, or neurological pathways implicated in disease pathogenesis, symptomatology, and treatment response mechanisms, offering potential therapeutic benefits, treatment alternatives, and personalized medicine options for patients with chronic pain, epilepsy, multiple sclerosis, post-traumatic stress disorder (PTSD), and other medical conditions requiring cannabinoid-based therapies or cannabinoid-derived pharmaceuticals in clinical practice. Key trends include the development of cannabinoid pharmaceuticals, synthetic cannabinoids, and cannabinoid receptor agonists that exhibit selective pharmacological activity, pharmacokinetic properties, and safety profiles in preclinical studies and clinical trials, as well as the integration of drug-device combination products, controlled-release formulations, and personalized dosing strategies into cannabis pharmaceutical development programs to enhance drug bioavailability, optimize treatment outcomes, and minimize treatment-related adverse effects in patient populations with diverse disease etiologies, therapeutic targets, and treatment response predictors. Additionally, there is a growing emphasis on cannabinoid research, translational medicine, and regulatory approval pathways that validate cannabinoid-based drug candidates, secure market access, and ensure patient access to safe, effective, and quality-assured cannabis medications in healthcare systems worldwide, as well as a growing focus on collaborative partnerships between pharmaceutical companies, academic research institutions, and regulatory agencies to advance cannabis pharmaceutical research, expedite drug development, and address unmet medical needs in global healthcare markets.

Cannabis Pharmaceuticals Market Drivers, Trends, Opportunities, and Growth Opportunities

This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Cannabis Pharmaceuticals market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Cannabis Pharmaceuticals survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Cannabis Pharmaceuticals industry.

Key market trends defining the global Cannabis Pharmaceuticals demand in 2024 and Beyond

The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.

Cannabis Pharmaceuticals Market Segmentation- Industry Share, Market Size, and Outlook to 2030

The Cannabis Pharmaceuticals industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Cannabis Pharmaceuticals companies scaling up production in these sub-segments with a focus on expanding into emerging countries.

Key strategies adopted by companies within the Cannabis Pharmaceuticals industry

Leading Cannabis Pharmaceuticals companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Cannabis Pharmaceuticals companies.

Cannabis Pharmaceuticals Market Study- Strategic Analysis Review

The Cannabis Pharmaceuticals market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-

• Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
• Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
• Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
• Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.

Cannabis Pharmaceuticals Market Size Outlook- Historic and Forecast Revenue in Three Cases

The Cannabis Pharmaceuticals industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.

Cannabis Pharmaceuticals Country Analysis and Revenue Outlook to 2030

The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.

North America Cannabis Pharmaceuticals Market Size Outlook- Companies plan for focused investments in a changing environment

The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Cannabis Pharmaceuticals market segments. Similarly, Strong end-user demand is encouraging Canadian Cannabis Pharmaceuticals companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Cannabis Pharmaceuticals market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.

Europe Cannabis Pharmaceuticals Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities

The German industry remains the major market for companies in the European Cannabis Pharmaceuticals industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Cannabis Pharmaceuticals market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.

Asia Pacific Cannabis Pharmaceuticals Market Size Outlook- an attractive hub for opportunities for both local and global companies

The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Cannabis Pharmaceuticals in Asia Pacific. In particular, China, India, and South East Asian Cannabis Pharmaceuticals markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.

Latin America Cannabis Pharmaceuticals Market Size Outlook- Continued urbanization and rising income levels

Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.

Middle East and Africa Cannabis Pharmaceuticals Market Size Outlook- continues its upward trajectory across segments

Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Cannabis Pharmaceuticals market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Cannabis Pharmaceuticals.

Cannabis Pharmaceuticals Market Company Profiles

The global Cannabis Pharmaceuticals market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie Inc, Bausch Health Companies Inc, Insys Therapeutics Inc, Jazz Pharmaceuticals Inc

Recent Cannabis Pharmaceuticals Market Developments

The global Cannabis Pharmaceuticals market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.

Cannabis Pharmaceuticals Market Report Scope

Parameters: Revenue, Volume Price

Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)

Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)

Qualitative Analysis

• Pricing Analysis
• Value Chain Analysis
• SWOT Profile
• Market Dynamics- Trends, Drivers, Challenges
• Porter’s Five Forces Analysis
• Macroeconomic Impact Analysis
• Case Scenarios- Low, Base, High

Market Segmentation:

By Brand

Sativex

Epidiolex

Others

Geographical Segmentation:

• North America (3 markets)
• Europe (6 markets)
• Asia Pacific (6 markets)
• Latin America (3 markets)
• Middle East Africa (5 markets)

Companies

AbbVie Inc

Bausch Health Companies Inc

Insys Therapeutics Inc

Jazz Pharmaceuticals Inc

Formats Available: Excel, PDF, and PPT